India has revoked its earlier ban on the export of malaria drug hydroxychloroquine (HCQ), which is being used to treat Covid-19. Revocation has been done in view of the humanitarian aspects of the pandemic. The ban on HCQ was revoked by India after U.S. President said that India could invite “retaliation” if it withheld supplies of HCQ. Earlier, the government of India placed HCQ on a restricted items list, and later put a blanket ban on any export of the drug.
Daily Current Affairs Quiz 2020
India has decided to licence paracetamol and HCQ in appropriate quantities to all its neighbouring countries who are dependent on its capabilities. It will also supply these essential drugs to some nations that have been particularly badly affected by the pandemic. The government will fulfill the pre-existing orders, mainly to the U.S., Brazil and European countries, as they have made advance payments on their orders. The orders will be fulfilled depending on the stock position and domestic demand for the drug, which would be continuously monitored.
